Innovative Neonatal Life Support System
Scientists at the University of Strathclyde, working in conjunction with local clinicians, have developed a simple but novel life support system (controlling blood flow & oxygenation) for babies. It has all the functional and control aspects of conventional ECMO systems but is much more compact and mobile. It also has the potential to address other perfusion markets.
Key Benefits
- Compared to conventional ECMO it provides:
- Reduced inflammatory response
- Reduced clotting factor consumption
- Compactness enabling easier access to the patient
- Enhanced mobility of patients, facilitating off-unit clinical investigations
- Better intervention opportunities for other applications, such as: Transplant Organ Perfusion, Isolated Limb Perfusion & Military Field/Traumatic Limb Injury
Applications
- Paediatric ECMO market
- Transplant Organ Perfusion
- Isolated Limb Perfusion & Military Field/Traumatic Limb Injury
IP Status
Contact is welcomed from organisations interested in developing, licensing or exploiting this technology. The University of Strathclyde is securing patent protection for this technology.
If you would like further information about
this opportunity please fill out the form below. Your enquiry will
be passed on to the relevant University who will respond to you directly.
